Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase ...

Thank you, Georgia, and thanks everyone for joining. At Codexis, Inc., our mission is to generate manufacturing solutions using biocatalytic enzymes. The number of siRNA medicines in development are ...

Braidwell, an investment firm that was launched by former Deerfield Management executive Alex Karnal and former ​Bridgewater Associates COO Brian Kreiter, is looking to double down on its bets on ...

The English session of the conference call will be held at 8:00 AM on March 26, 2026 Beijing Time (8:00 PM U.S. Eastern Time on March 25, 2026), and the Mandarin session of the conference call will be ...

This includes strengthening its position as a regional and global reference authority Read more at The Business Times.

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

Visitors check out a sandbox demonstration highlighting future industrial development at the exhibition hall of a biopharmaceutical industry cluster in Xiamen, Fujian province. [Photo provided to ...

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2025 Annual Results. Business Highlights Cash and cash ...

Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline catalysts.

Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...